期刊文献+

替米沙坦与贝那普利降压及逆转左室肥厚的疗效观察 被引量:5

Clinical Effects of Telmisartan and Benazepril on Hypertension and Reversing Left Ventricular Hypertrophy
暂未订购
导出
摘要 目的:分析替米沙坦与贝那普利治疗轻中度高血压的疗效和对左心室肥厚及心功能的影响。方法:将轻中度高血压病人115例随机分为替米沙坦组和贝那普利组,在服药前和服药后4周、12个月测血压,服药前和服药后12个月测量左室舒张末内径(LVD)、左室舒张期室间隔厚度(IVST)、左室后壁厚度(LVPWT)、左室射血分数(LVEF)、左室短轴缩短率(FS)、二尖瓣口舒张早、晚期血流峰值速度E/A比值。结果:服药4周后两组血压均明显下降(P<0.05),替米沙坦组稍优于贝那普利组,但两组间比较差异无显著性,两药对心率均无影响。治疗12个月后两组LVEF、FS有所升高,但差异无显著性,LVD、IVST、LVPWT及左室重量指数(LVM I)均明显降低(P<0.01),E/A比值明显升高(P<0.05)。结论:替米沙坦、贝那普利不仅能降低血压,还能明显减轻左室肥厚,改善左室舒张功能。 Objective:To investigate the effects of telmisartan and benazepril on hypertension and reversing left ventricular hypertrophy,cardiac function through contrast analysis.Method:115 cases of hypertension in the stage 1-2 range were randomly divided into telmisartan group and benazepril group.Blood pressures were measured before taking drug,4 weeks and 12 months after taking drug.Left ventricular end diastolic diameter(LVEDD),Interventricular septum thickness diastolic(IVSTd),left ventricular posterior wall thickness(LVPWt),Left ventricular ejection(LVEF),Fraction shortening(FS),E/A were measured with Doppler echocardiography before have druges,12 months after have druges.Result:Blood pressures of two groups were significantly decreased(P〈0.05),blood pressures of telmisartan group dropped more than the group of benazepril,But there was no significant difference(P〉0.05) between two groups,and two drugs had no effect on heart ratio.LVEF and FS of two groups were significantly improved after 12 months,without significant difference(P〉0.05).IVSTd,LVEDD,LVPWt and left ventricular mass index(LVMI) dropped significantly(P〈0.01),and E/A improved significantly(P〈0.05)after 12 months.Conclusion:Telmisartan and benazepril could not only reduce blood pressure but also abate left ventricular hypertrophy significantly and regulate left ventricular diastolic function
出处 《河北医学》 CAS 2011年第5期589-592,共4页 Hebei Medicine
关键词 替米沙坦 贝那普利 高血压 左心室肥厚 Telmisartan; Benazepril; Hypertension; Left ventricular hypertrophy;
  • 相关文献

参考文献6

二级参考文献40

  • 1吴伦宽,方颖,吴立荣.多重受体阻断对不同血管紧张素Ⅱ水平高血压患者血压、血管活性物质的影响[J].临床内科杂志,2004,21(9):600-602. 被引量:4
  • 2邢淑华,董传海,崔明,蔺学燕.肾素-血管紧张素系统抗高血压药物临床研究[J].中国药师,2005,8(8):691-693. 被引量:11
  • 3刘力生 龚兰生.临床高血压病学[M].天津:天津科学出版社,1991.11-263.
  • 4卫生部心血管系统药物临床药理基地.心血管系统药物临床研究指导原则(草案)[J].中国临床药理学杂志,1988,4(4):245-245.
  • 5Siragy H. Angiotensin II receptor blockers: review of the binding characteristics. Am J Cardiol, 1999, 84: 3S-8S.
  • 6Neutel JM, Smith DHG. Dose response ane antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv Ther, 1998, 15: 206-217.
  • 7Myers MG. Suggested guidelines for determining the trough-to-peak ratio of antihypertensive drugs. Am J Hypertens, 1996, 9: 76S-82S.
  • 8Mallion JM, Siche JP, Lacourciere Y, et al. ABPM comparison of antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens, 1999, 13: 657-664.
  • 9Lipicky RJ. Trough/peak ratio: the rationale behind the United States Food and Drug Administration reco mmendations. J Hypertens, 1994, 12(Suppl 8): S17-S19.
  • 10Zannad F, Matzinger A, Larche J. Trough/peak ratios of once-daily angiotensin converting enzyme inhibitors and calcium antagonists. Am J Hypertens, 1996, 9: 633-643.

共引文献160

同被引文献25

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部